A clinician-grade copilot for every woman in mid-life — built on longitudinal evidence and continuous physiology.
The Biological Silo
"My doctor fixed my hormones, but no one asked about my anxiety."
The Episodic Silo
"Once the baby was born, I felt like the system forgot I existed."
The Invisible Silo
"I'm treating symptoms in isolation without anyone seeing the full picture."
The Consequence
of women feel their mental-health concerns are overlooked during life transitions.
Every transition forces re-establishing care and loses longitudinal data that could signal risk.
Data Gap
Most clinical AI is trained on cohorts that systematically under-weight women — especially mid-life. Wearable training corpora skew male, athletic, and young.
Evidence Gap
Standard tools miss menopause type and timing, hormonal-metabolic interactions, treatment trajectory, and longitudinal risk acceleration.
Knowledge Gap
Women are diagnosed later than men for the same conditions. Care is fragmented across OB-GYN, PCP, cardiology, oncology, and behavioural health.
U.S. women enter menopause each year
with symptoms receive no treatment
killer of women — heart disease
increased dementia risk after early menopause
Closing the knowledge, evidence, and data gaps in middle-aged women's health — a digital twin built on longitudinal evidence and continuous physiology.
For Clinicians
A clinician-grade intelligence layer that surfaces the full picture — not just today's labs, but the trajectory, the phenotype, and the evidence that standard tools miss.
Two screens. Sixty seconds. No new workflow.
For Patients
A personalised health companion that connects wearable data, symptom tracking, and AI coaching — keeping the doctor in the loop, always.
Privacy-first consent, on by default.
Clinical context + Continuous physiology + Real-world engagement = the first true digital twin for women's health.
EMR · Clinical Context
Longitudinal women's EMR.
152,184 women · ages 45–55 · 2-yr lookback · followed to MACE. The deepest longitudinal cohort of mid-life women ever assembled.
Wearable · Continuous Physiology
Continuous biometrics — 24×7, in real life.
HRV, resting HR, skin temperature, sleep stages, activity, and stress — streaming in real time. Population-scale physiology, not lab proxies.
DTx · Engagement & Evidence
65K users and proven outcomes.
Real-world mid-life engagement. FDA-cleared digital therapeutics. Published clinical effectiveness. The most-used menopause app.
Clinical Data Partner
Access to the most comprehensive longitudinal cohort of mid-life women ever assembled — 152,184 women, followed to cardiovascular outcomes. Co-developed with leading Mayo Clinic women's health and menopause researchers.
Wearable & Biometric Partner
Direct integration with Galaxy Watch 8 and the Samsung Health SDK — real-life biometrics at population scale, not lab proxies. Continuous physiology streaming into a purpose-built time-series infrastructure.
Traction
Patents granted. Core models trained and validated. A digital twin platform tracking 5,000 patients across a 7-year longitudinal journey. The infrastructure is built — and the pipeline is live.
Women longitudinal cohort
Active app users
Cleared DTx — MamaLift Plus
MACE prediction accuracy
TAM
Global women's-health AI
Total addressable by 2030 — women's-health AI + digital therapeutics + remote patient monitoring + clinical decision support, worldwide.
SAM
U.S. middle-aged women
Perimenopause, menopause, maternal and cardiometabolic. Clinician CDS at ~$8K × 200K U.S. OB-GYN + women's-health PCPs, plus the patient app.
SOM
3-year beachhead
Mayo + Samsung co-developed launch, Hometown Clinics pilot, plus 2–3 contracted health systems. ~5,000 clinicians and ~250,000 women in twin-enabled care by Year 3.
We're selectively sharing more with strategic partners and early collaborators. If you're building the future of women's health, let's talk.